Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / IBD BREAKOUT
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
66,653
-
Shares change
-
+2,882
-
Total reported value, excl. options
-
$2,438,377
-
Value change
-
+$105,424
-
Number of buys
-
3
-
Number of sells
-
-3
-
Price
-
$36.58
Significant Holders of INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) as of Q3 2024
9 filings reported holding BOUT - INNOVATOR ETFS TRUST - IBD BREAKOUT as of Q3 2024.
INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66,653 shares
.
Largest 10 shareholders include CITADEL ADVISORS LLC (32,664 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (29,827 shares), OSAIC HOLDINGS, INC. (3,000 shares), Asset Dedication, LLC (577 shares), HOLLENCREST CAPITAL MANAGEMENT (450 shares), AdvisorNet Financial, Inc (100 shares), UBS Group AG (29 shares), DHJJ Financial Advisors, Ltd. (5 shares), WELLS FARGO & COMPANY/MN (1 shares), and MORGAN STANLEY (1 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.